Dimensional Fund Advisors LP Zentalis Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 335,966 shares of ZNTL stock, worth $564,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares

335,966

Previous 447,400 24.91%

Holding current value

$564,422

Previous $711,000 45.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$1.04 - $1.63 $115,891 - $181,637	-111,434 Reduced 24.91%	335,966 $389,000
Q1 2025 May 13, 2025	SELL	$1.59 - $3.24 $91,593 - $186,643	-57,606 Reduced 11.41%	447,400 $711,000
Q4 2024 Feb 13, 2025	SELL	$2.7 - $4.03 $1,722 - $2,571	-638 Reduced 0.13%	505,006 $1.53 Million
Q3 2024 Nov 07, 2024	SELL	$2.9 - $4.57 $350,955 - $553,056	-121,019 Reduced 19.31%	505,644 $1.86 Million
Q2 2024 Aug 09, 2024	SELL	$4.09 - $16.13 $396,701 - $1.56 Million	-96,993 Reduced 13.4%	626,663 $2.56 Million
Q1 2024 May 10, 2024	SELL	$10.83 - $16.49 $4,082 - $6,216	-377 Reduced 0.05%	723,656 $11.4 Million
Q4 2023 Feb 07, 2024	BUY	$9.84 - $20.13 $2.36 Million - $4.83 Million	239,714 Added 49.5%	724,033 $11 Million
Q3 2023 Nov 09, 2023	BUY	$19.63 - $28.29 $2.17 Million - $3.12 Million	110,415 Added 29.53%	484,319 $9.72 Million
Q2 2023 Aug 09, 2023	BUY	$17.41 - $30.05 $889,772 - $1.54 Million	51,107 Added 15.83%	373,904 $10.5 Million
Q1 2023 May 12, 2023	BUY	$16.14 - $24.94 $3.06 Million - $4.73 Million	189,766 Added 142.65%	322,797 $5.55 Million
Q4 2022 Feb 09, 2023	BUY	$18.07 - $25.6 $1.78 Million - $2.53 Million	98,683 Added 287.3%	133,031 $2.68 Million
Q3 2022 Nov 10, 2022	SELL	$20.23 - $31.73 $755,833 - $1.19 Million	-37,362 Reduced 52.1%	34,348 $744,000
Q2 2022 Aug 12, 2022	SELL	$17.91 - $52.25 $354,474 - $1.03 Million	-19,792 Reduced 21.63%	71,710 $2.01 Million
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $3.8 Million - $7.4 Million	91,502 New	91,502 $4.22 Million

Others Institutions Holding ZNTL

# of Institutions

124

Shares Held

60.6M

Call Options Held

Put Options Held

22K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $95.7M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Zentalis Pharmaceuticals, Inc. Transaction History